Net Income

A new survey shows most family firms expect a leadership change soon, but few are prepared, creating a high-stakes gap between intent and action.

With two high-profile board appointments, Stellaromics signals its ambition to dominate the 3D spatial omics market with its advanced Pyxa™ platform.

A new partnership between GeminiBio and Tolemy Bio introduces aiMOS™, an AI-powered service designed to cut costs and boost consistency in cell therapy production.

A new report, based on $34B in spend data, uncovers massive waste in SaaS, cloud, and mobile, offering a playbook for CIOs to regain control.

With $4.5M donated last year, MAC's iconic lipstick program has evolved from an AIDS crusade into a global force for racial, gender, and environmental justice.

The tech firm launches a dedicated healthcare vertical, using AI to simplify complex EHRs and give clinicians more time for patient care.

The financial services firm posted lower delinquency and loss rates for January, but is it a sign of a healthier consumer or savvy internal strategy?

The drive-thru coffee giant is moving into your kitchen, taking on Starbucks and Nestlé with its new retail line. But can its 'Dutch Luv' succeed on shelves?

Amid major restructuring and a strategic asset sale, Standard BioTools' upcoming annual results will reveal its progress toward profitability in a tough market.

A new three-year deal with Go Rentals aims to elevate the Hoag Classic's luxury experience, blending high-end service with a powerful philanthropic mission.

Enanta Pharmaceuticals unveils promising data for EDP-978, an oral drug targeting the root cause of conditions like chronic hives, asthma, and eczema.

FPX Nickel's massive Baptiste project could supply low-carbon nickel for EVs, but it first needs to win over the public and regulators. Here's what's at stake.

A new framework from LatticeFlow AI and Unique AI translates Swiss financial regulations into auditable code, paving the way for safer AI in banking.

Israeli startup Protai is set to reveal promising preclinical data for its cancer drug, PRT-001, powered by its unique proteomics-aware AI platform.

Global match-fixing saw a slight decline in 2025, driven by AI detection. However, the fight intensifies as corruption shifts to new regions and sports.

DAHON's new LUNDEN tri-fold bikes integrate DAHON-V Tech, promising the rigidity and ride quality of a full-size bike in a compact, portable package.

Swiss pharma Santhera appoints Stifel as advisor, a strategic move to fuel the global rollout of its DMD drug AGAMREE amid a complex biotech funding market.

The Baltic real estate giant divests a key Latvian asset at a profit, unlocking millions in capital for new investments and signaling a hot logistics market.

Following a landmark FDA approval, IceCure Medical's long-serving CFO is exiting, placing the company at a pivotal financial crossroads for its new treatment.

With its IPO complete, Cambridge Acquisition Corp. enters a disciplined SPAC market with a clear focus on wellness, hemp, and psychedelic tech targets.